Last Updated: May 11, 2018
Filed under:
Print Friendly, PDF & Email

Positioned to implement President Trump’s recommendations with existing solutions to reduce pharmaceutical costs and stimulate market competition CHARLOTTE, N.C. — Premier Inc. (NASDAQ: PINC), a leading healthcare improvement company, applauds many of the actions being taken by the White House (more…)

Last Updated: May 8, 2018
Filed under:
Print Friendly, PDF & Email

By Blair Childs, senior vice president, public affairs, Premier We commend House Energy and Commerce Committee leaders, Chairmen Michael Burgess, Greg Walden (R-OR) and Markwayne Mullin (R-OK), for focusing on the Overdose Prevention and Patient Safety Act (H.R. 3545) during (more…)

Last Updated: March 29, 2018
Filed under:
Print Friendly, PDF & Email

The Healthcare Blog: Michael Alkire: Pharmaceuticals play a major role in today’s population health era – they can prevent and cure disease, improve or maintain wellness and slow progression of existing conditions. Yet, their promise can also be a curse if (more…)

Last Updated: March 16, 2018
Filed under:
Print Friendly, PDF & Email

Majority say shortages are affecting patient care, resulting in increased costs and cancelled or delayed surgical procedures CHARLOTTE, N.C.— A new survey of Premier members revealed more than 96 percent of member health systems are experiencing moderate-to-severe shortages of injectable (more…)

Last Updated: November 8, 2017
Filed under:
Print Friendly, PDF & Email

By Blair Childs, senior vice president of public affairs, Premier Premier and its members commend the FDA for taking important steps through draft guidance to stem drug manufacturers’ abuse of the Risk Evaluation and Mitigation Strategy (REMS) – a process that (more…)